NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Non-Invasive Blood Glucose Monitoring Devices Market Size and Forecast – 2026 to 2033

The global non-invasive blood glucose monitoring devices market is estimated to be valued at USD 28.2 Mn in 2026 and is expected to reach USD 80.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.1% during the forecast period (2026 to 2033).

Key Takeaways from the Non-Invasive Blood Glucose Monitoring Devices Market Report

• Based on Modality, demand is expected to remain high for wearable devices during the assessment period.
• Based on technology, EM waves segment is projected to account for 35.2% of the global non-invasive glucose monitoring devices market share in 2026.
• North America, with an estimated share of 35% in 2026, is set to dominate the global non-invasive blood glucose monitoring devices industry.
• Europe remains the second-leading market for non-invasive blood glucose monitoring devices, representing a market share of 25% in 2026.
• Asia Pacific is poised to become a hotbed for non-invasive blood glucose monitoring device manufacturers, capturing 20% of the global market share by 2026

Non-Invasive Blood Glucose Monitoring Devices Market Overview

The global non-invasive blood glucose monitoring devices market is projected to grow rapidly during the forecast period. This can be attributed to increasing prevalence of diabetes and rising demand for pain-free glucose monitoring solutions in the home care setting segment.

Non-invasive technologies eliminate the need for finger-pricking, addressing one of the major barriers associated with traditional blood glucose monitoring. As a result, there is a rising demand for non-invasive blood glucose monitoring devices in the healthcare and home care sectors.

Continuous advancements in biosensing and optical technologies are empowering companies to develop reliable and accurate non-invasive glucose monitoring systems. For instance, researchers at Indian Institute of Technology Delhi recently developed a saliva-based biosensor to monitor glucose non-invasively.

However, problems with accuracy, calibration, and consistent glucose readings without taking blood are still major obstacles for market growth. Strict regulations also slow down product approvals as well as commercial use.

Current Events and Their Impact on the Non-Invasive Blood Glucose Monitoring Devices Market

Segmental Insights 

Non-Invasive Blood Glucose Monitoring Devices Market Insights, By Technology: EM Waves Technology Reigns Supreme in the Market

As per Coherent Market Insights latest analysis, EM waves segment is expected to dominate the market, accounting for 35.2% of the market share in 2026. This technology stands out because it allows blood glucose measurement without the need for needles or blood samples.

EM-based devices detect changes in glucose concentration by sending harmless electromagnetic signals through the skin. This makes the process of blood glucose monitoring painless, quick, and convenient for users.

Devices using EM wave technology are gaining popularity as more people with diabetes look for easier and more comfortable monitoring options. The combination of accuracy, comfort, and ease of use is driving more adoption among patients and healthcare providers.

Leading players are focusing on creating new EM waves-based devices to meet evolving healthcare needs as well as capitalize on emerging opportunities. For instance, Afon Technology recently announced the development of Glucowear, a completely non-invasive continuous glucose monitor.

Glucowear uses RF/microwave technology (i.e., electromagnetic waves) to measure glucose levels with no needle required. Such developments could further boost growth of the target segment during the forecast period.

Regional Insights 

North America Dominates the Non-Invasive Blood Glucose Monitoring Devices Market

North America is the largest market for non-invasive blood glucose monitoring devices, making up 35% of the world’s market in 2026. The high prevalence of diabetes in the region is driving market growth.

The number of people with diabetes is increasing significantly across nations like the U.S. and Canada. This, in turn, is expected to create strong demand for easier and pain-free monitoring solutions.

The region benefits from advanced healthcare infrastructure and high awareness about health and wellness. These factors are encouraging adoption of innovative glucose monitoring technologies in North America.

There is also a rising trend of using wearable glucose monitoring devices in the region. Companies and healthcare organizations are promoting these devices for easier, non-invasive diabetes management.

For example, in June 2026, the Department of Health and Human Services, led by U.S. Health Secretary Robert F. Kennedy Jr. announced plans to launch an advertising campaign to encourage Americans to adopt wearable devices, such as those that measure heart rate or blood glucose levels. These initiatives will further boost growth of the non-invasive blood glucose monitoring devices market in North America.

Asia Pacific Emerges as Hub for Non-Invasive Glucose Tech

Asia Pacific is expected to remains the third largest market for non-invasive blood glucose monitoring devices, accounting for 20% of the global market share for the year 2026. This is attributable to rising incidence of lifestyle-related diseases like diabetes and heart disorders in the region.

The region is witnessing improved healthcare accessibility as well as increasing urbanization, which boost adoption of modern health technologies. Growing awareness about non-invasive monitoring methods also supports market expansion.

Non-Invasive Blood Glucose Monitoring Devices Market Outlook – Country-wise

U.S. Non-Invasive Blood Glucose Monitoring Devices Market Trends

The United States is expected to lead the global non-invasive blood glucose monitoring devices industry during the forecast period. This is attributable to high prevalence of diabetes, increasing awareness about diabetes management, innovations in non-invasive technology, and a strong preference for pain-free and convenient monitoring solutions.

Consumers in the U.S. are increasingly seeking wearable and smart devices for continuous glucose monitoring. This is expected to boost sales of non-invasive blood glucose monitoring devices in the nation during the forecast period.

Non-invasive blood glucose monitoring devices are becoming more accessible to a broader population in the U.S. This is due to increased efforts from the government, healthcare organizations, and leading retailers.

For instance, in October 2026, Walmart became the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in physical stores. Previously, Lingo was available only through Abbott's website and Amazon. The device is now rolling out to over 3,500 Walmart locations and online.

China Non-Invasive Blood Glucose Monitoring Devices Market Forecast

China is emerging as one of the fastest-growing non-invasive blood glucose monitoring device markets. This is mostly due to rising number of diabetes patients, rapid urbanization, and increasing disposable income, which allows more people to invest in advanced health-monitoring devices.

In addition, Chinese government is promoting digital health initiatives as well as supporting the development of innovative medical technologies. This will likely create lucrative growth opportunities for non-invasive blood glucose monitoring device companies during the forthcoming period.

Growing awareness about diabetes management, rising popularity of wearable devices, and increasing smartphone penetration are key trends contributing to market expansion. Local manufacturers and global companies are also collaborating to introduce cost-effective and technologically advanced devices in the market.

Market Concentration and Competitive Landscape

Leading manufacturers of non-invasive blood glucose monitoring devices are increasing their R&D investments to develop advanced solutions. For instance, they are creating wearable devices that provide continuous glucose monitoring without finger pricks. For example, researchers at MNNIT Prayagraj recently developed a non-invasive glucose monitoring device that utilizes electromagnetic technology, eliminating the need for finger pricks.

Many companies are using AI-powered predictive analytics to anticipate glucose fluctuations. There is also a rising trend of developing optical or electromagnetic sensing technologies for faster, more accurate readings. Similarly, industry players are employing inorganic growth strategies like mergers & acquisitions, partnerships, and collaborations.

Non-Invasive Blood Glucose Monitoring Devices Industry News

• In August 2024, Medtronic received U.S. FDA approval for its Simplera™ continuous glucose monitor (CGM). This is the company’s first disposable, all-in-one CGM, designed to be half the size of previous Medtronic CGMs.
• In June 2024, Abbott Laboratories received U.S. FDA clearance for its two novel OTC continuous glucose monitoring systems – Lingo and Libre Rio. These new CGM systems are designed to meet the needs of adults with Type 2 diabetes and consumers interested in monitoring their glucose levels.
• In February 2024, DexCom, Inc. launched its new continuous glucose monitor called Dexcom ONE+. It is designed to be easier to use and smaller than previous models.
• In March 2024, the FDA approved the first over-the-counter continuous glucose monitor. The Dexcom Stelo Glucose Biosensor System is a continuous glucose monitor (CGM) for people 18 and older who do not use insulin.

Market Report Scope 

Non-Invasive Blood Glucose Monitoring Devices Market Drivers

Increasing Prevalence of Diabetes

Rising prevalence of diabetes is a major concern globally. According to the International Diabetes Federation (IDF), diabetes is expected to affect around 643 million people in 2030 and 853 million by 2050. This surge is expected to boost growth of the non-invasive blood glucose monitoring devices market during the forecast period.

Long-term complications from high blood sugar can damage organs and tissues over time if not controlled properly. Non-invasive blood glucose monitoring devices help patients and doctors track blood sugar levels in real time, making diabetes management easier.

Technological Advancements in Non-Invasive Monitoring Techniques

Technological innovations are helping meet the need for painless glucose monitoring through new non-invasive methods such as transdermal optical, spectroscopic, and ultrasonic techniques, which do not require drawing blood. These advancements are expected to boost the market during the forthcoming period.

For example, a study published in June 2023 in the American Journal of Translational Research described a flexible biosensor made with gold nanostructures. This sensor had tiny gold needle-like structures on a flexible chip, which increased the area for enzymes to attach, making it more sensitive.

Non-Invasive Blood Glucose Monitoring Devices Market Opportunities

Development of Smartphone-based Monitoring Solutions

Smartphone-based monitoring solutions can help improve patient compliance by offering non-invasive and pain-free ways to check glucose levels. Researchers are exploring ideas like apps connected to Bluetooth-enabled patches or sensors that can measure glucose in the fluid under the skin and send the readings directly to a smartphone.

According to a study published by MDPI in 2022, smartphone-integrated portable, wearable, and implantable glucose monitors are advancing quickly. These devices aim to make glucose monitoring easier, more comfortable, and accurate, while allowing real-time tracking. Their development could create new growth opportunities in the market.

Non-Invasive Blood Glucose Monitoring Devices Market Trends

Transition Towards Continuous Glucose Monitoring Solutions

The shift towards continuous glucose monitoring solutions is positively impacting the non-invasive blood glucose monitoring devices market growth. Continuous glucose monitoring (CGM) devices track glucose levels in real time and alert patients to high or low readings. They offer a more convenient and proactive alternative to traditional finger-prick tests.

According to the Royal Society of Chemistry publication “Recent Advances in Optical Sensors for Continuous Glucose Monitoring” (July 2022), monitoring blood glucose during physical activity is critical, as both hypo- and hyperglycemia can significantly impact patient health. CGM devices enable diabetic individuals to better manage their diet, exercise, and medication by providing continuous, real-time glucose data, supporting a healthier and more balanced lifestyle.

Non-Invasive Blood Glucose Monitoring Devices Market Restraints

Regulatory Compliance Issues and Product Recalls

The growth of non-invasive blood glucose monitoring devices is slowed down by regulatory challenges and product safety issues. These devices use new technologies like near-infrared spectroscopy or reverse iontophoresis to measure glucose from skin or other body tissues instead of blood. However, these methods are still in early development and need more clinical testing to prove they are as accurate and reliable as traditional finger-prick tests.

For example, in April 2023, Abbott Laboratories recalled millions of FreeStyle Libre glucose monitoring devices due to problems with rechargeable lithium-ion batteries. The batteries could overheat, swell, or catch fire if not used with the provided charging accessories. This shows how safety concerns can limit market growth.

Analyst Opinion (Expert Opinion)

• The non-invasive blood glucose monitoring devices market is growing rapidly as cases of diabetes continues to surge. These devices are widely used for the measurement of blood glucose levels, without drawing blood, puncturing the skin, or causing pain or trauma.
• Despite improvements, non-invasive glucose monitoring methods—such as spectroscopy, electromagnetic sensing, and reverse iontophoresis—are still working on becoming more accurate and reliable. Advancements in these areas could make non-invasive blood glucose monitoring devices more popular among patients and healthcare professionals.
• Companies entering this market should prioritize technological innovation to enhance device accuracy as well as reliability. Simultaneously, advocating for stronger regulatory framework will be important to keep patients safe and make people trust the system.

Market Segmentation

• Technology Insights (Revenue, USD Mn, 2021 - 2033)
  • EM Waves
  • Transdermal
  • Optical
  • Enzymatic
• Modality Insights (Revenue, USD Mn, 2021 - 2033)
  • Wearable
  • Non-wearable/Benchtop
  • Embedded Devices
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Homecare setting
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Baxter International Inc.
  • Dexcom, Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • Senseonics Holdings, Inc.
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd.
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S

Sources

Primary Research Interviews

• Interviews with key opinion leaders (KOLs) in the field of diabetes management and wearable medical devices.
• Discussions with product development teams from companies specializing in non-invasive glucose monitoring technologies.
• Conversations with healthcare professionals and endocrinologists regarding the adoption and efficacy of non-invasive glucose monitoring devices.

Databases

• PubMed
• ScienceDirect
• IEEE Xplore
• Scopus
• Web of Science

Magazines

• IEEE Spectrum
• Medical Design & Outsourcing
• MedTech Dive
• Medical Device and Diagnostic Industry (MD+DI)

Journals

• Journal of Diabetes Science and Technology
• Sensors (MDPI)
• Diabetes Technology & Therapeutics
• Biomedical Optics Express
• IEEE Transactions on Biomedical Engineering

Newspapers

• The Times of India
• The Hindu
• Economic Times
• Mint
• Business Standard

Associations

• International Diabetes Federation (IDF)
• American Diabetes Association (ADA)
• Diabetes India
• Indian Medical Association (IMA)
• Association for the Advancement of Medical Instrumentation (AAMI)

Public Domain Sources

• Wikipedia articles on non-invasive glucose monitoring technologies and related devices.
• Government publications and patents related to medical devices and glucose monitoring technologies.
• Open-access research articles and preprints available on platforms like arXiv and bioRxiv.

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years